Symbol="AGIO"
AssetType="Common Stock"
Name="Agios Pharm"
Description="Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts."
CIK="1439222"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="88 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1481784000"
EBITDA="-367183008"
PERatio="None"
PEGRatio="0"
BookValue="17.3"
DividendPerShare="0"
DividendYield="0"
EPS="-3.78"
RevenuePerShareTTM="0.365"
ProfitMargin="0"
OperatingMarginTTM="-18.59"
ReturnOnAssetsTTM="-0.2"
ReturnOnEquityTTM="-0.201"
RevenueTTM="20147000"
GrossProfitTTM="12536000"
DilutedEPSTTM="-3.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.202"
AnalystTargetPrice="38.83"
TrailingPE="-"
ForwardPE="2.466"
PriceToSalesRatioTTM="164.39"
PriceToBookRatio="1.623"
EVToRevenue="107.31"
EVToEBITDA="-2.763"
Beta="0.953"
num_52WeekHigh="34.76"
num_52WeekLow="21.07"
num_50DayMovingAverage="26.71"
num_200DayMovingAverage="26.49"
SharesOutstanding="55581000"
DividendDate="None"
ExDividendDate="None"
symbol="AGIO"
open="26.75"
high="27.08"
low="26.52"
price="26.66"
volume="274682.00"
latest_trading_day="2023-08-11"
previous_close="26.79"
change="-0.13"
change_percent="-0.4853%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="443506"
Change_recent_avg="0.03"
Delta_recent_avg="0.93"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="1118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_negative_thumbnail_id_2="175"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="700"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
